Home
Conditions
Lymphoproliferative Disorders

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,045 public trials 2,032 recruiting studies

Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

Cloretazine (VNP40101M) With Hematopoietic Cell Transplantation for Hematologic Malignancies

NCT00521859

Conditions: Hematologic Diseases, Hematologic Malignancies, Hematologic Neoplasms, +12 more
Locations: UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Bone Marrow Transplantation in Treating Patients With Lymphoma

NCT00002829

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +26 more
Locations: University of Texas - MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma

NCT00002524

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations: MD Anderson Cancer Center Orlando Orlando, Florida, United States

University of Texas - MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Decitabine and Peripheral Stem Cell Transplantation in Treating Patients Who Have Relapsed Following Bone Marrow Transplantation for Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia

NCT00002832

Conditions: Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +23 more
Locations: University of Texas - MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Alemtuzumab (CAMPATH 1H) Associated to G-CSF in Adult Patients With Refractory Acute Lymphocytic Leukemia

NCT00773149

Conditions: Acute Lymphocytic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: Saint Antoine Hospital, Hematology Unit Paris, France

View Trial Details

Completed

Phase II Study of ZIO-101 in Advanced Blood and Bone Marrow Cancers

NCT00421213

Conditions: Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +14 more
Locations: Miami, Florida, United States

Chicago, Illinois, United States

Bethesda, Maryland, United States

Fargo, North Dakota, United States

View Trial Details

Completed

Study of ZIO-101 in Multiple Myeloma

NCT00303199

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Little Rock, Arkansas, United States

West Hollywood, California, United States

Miami, Florida, United States

Bethesda, Maryland, United States

View Trial Details

Completed

A Phase I Trial of ZIO-101 in Hematologic Cancers

NCT00592046

Conditions: Acute Leukemia, Anemia, Anemia, Refractory, +31 more
Locations: Houston, Texas, United States

View Trial Details

Completed

Donor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematologic Cancer or Myelodysplastic Syndrome

NCT00732316

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +30 more
Locations: Asan Medical Center - University of Ulsan College of Medicine Seoul, South Korea

View Trial Details

Completed

Dasatinib and Vorinostat in Treating Patients With Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia or Acute Lymphoblastic Leukemia

NCT00816283

Conditions: Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +21 more
Locations: City of Hope Comprehensive Cancer Center Duarte, California, United States

City of Hope Medical Group Pasadena, California, United States

View Trial Details

Lymphoproliferative Disorders

Lymphoproliferative Disorders trial results

Related conditions